M&A Deal Summary

Fresenius Acquires Fenwal

On July 21, 2012, Fresenius acquired healthcare services company Fenwal from TPG for 1.1B USD

Acquisition Highlights
  • This is Fresenius’ 1st transaction in the Healthcare Services sector.
  • This is Fresenius’ 3rd largest (disclosed) transaction.
  • This is Fresenius’ 1st transaction in the United States.
  • This is Fresenius’ 1st transaction in Illinois.

M&A Deal Summary
Date 2012-07-21
Target Fenwal
Sector Healthcare Services
Buyer(s) Fresenius
Sellers(s) TPG
Deal Type Add-on Acquisition
Deal Value 1.1B USD
Advisor(s) Barclays Investment Bank
Evercore Group (Financial)

Target

Fenwal

Lake Zurich, Illinois, United States
Fenwal, Inc. is one of the world's largest suppliers of products and services to the transfusion medicine industry. Fenwal was created with a single purpose: to provide high quality, innovative blood collection and processing products and services that support customers' missions to improve and save lives.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Fresenius

Bad Homburg Vor Der Hoehe, Germany
Category Company
Founded 1912
Sector Medical Products
Employees190,863
Revenue 22.3B EUR (2023)
DESCRIPTION

Fresenius provides medical products, services for dialysis, hemodialysis, peritoneal dialysis. Fresenius was founded in 1912 and is based in Bad Homburg Vor Der Hoehe, Germany.

DEAL STATS #
Overall 2 of 8
Sector (Healthcare Services) 1 of 6
Type (Add-on Acquisition) 1 of 5
State (Illinois) 1 of 1
Country (United States) 1 of 1
Year (2012) 1 of 1
Size (of disclosed) 3 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-08-11 Dabur Pharma

Gurgaon, India

Dabur Pharma Ltd. is committed to the discovery, development and marketing of drugs that fight cancer. Dedicated to its mission of making cancer therapy available to more and more people, it has been expanding ever since inception.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-09-13 Rhoen-Klinikum Ag /43 Hospitals/

Germany

RHON-KLINIKUM Aktiengesellschaft operates as a healthcare provider in Germany.

Buy €3.1B

Seller(S) 1

SELLER

TPG

Fort Worth, Texas, United States

Investor Investor Investor Investor

Category Private Equity Firm
Founded 1992
PE ASSETS 137.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

TPG Capital is a global, mega-sized private investment firm that manages a family of funds focused on private equity, real estate, venture capital, public equity and debt investing. TPG invests in opportunities across a broad range of industries and geographies. TPG generally seeks to invest in established businesses that can benefit from the Firm's operational experience and connections. Industries of interest include consumer, retail, healthcare, industrials, digital media, natural resources, energy, real estate, technology, and software. TPG was formerly known as Texas Pacific Group and was originally established in 1992 by David Bonderman, James Coulter and William Price. The Firm is based in Forth Worth, Texas with additional offices in Europe, Asia, and Australia.

DEAL STATS #
Overall 88 of 267
Sector (Healthcare Services) 3 of 11
Type (Add-on Acquisition) 41 of 94
State (Illinois) 2 of 6
Country (United States) 64 of 193
Year (2012) 10 of 15
Size (of disclosed) 37 of 71
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-07-16 Par Pharmaceutical Companies

Woodcliff Lake, New Jersey, United States

Par Pharma specializes in developing, licensing, manufacturing, marketing and distributing generic drugs.

Buy $1.9B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-07-25 HCP Packaging

Shanghai, China

HCP Packaging is a designer and manufacturer of prestige primary packaging containers for the cosmetics, skincare and fragrance industries. HCP Packaging is based in Shanghai, China.

Buy $500M
Mergr

Product

Company

Legal